Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · regulatory

CG MedTech clears regulatory hurdle for spinal implant sales in Colombia

8 October 2026 · By · Wire by Fusion42

Published

8 October 2026

Topic

regulatory

◆ Sectors

Medtech

◆ Geography

Colombia

◆ Source

Read at koreabiomed.com →

◆ Verified

Fusion42 · 11 October 2026 · Fusion42 review

CG MedTech received Class IIb medical device regulatory approval from Colombia's INVIMA for its INNOVERSE Spinal System and plans to launch sales through local partner IMPLAMEQ, including training and academic activities for healthcare providers.

This Wire brief sits within Fusion42's coverage of Medtech.

◆ ◆ The Wire takeaway

Your Medtech company can now access the Colombian spinal implant market where CG MedTech just cleared the regulatory barrier. Partnering with local distributors and running training now opens doors for sustained commercial growth there.

◆ Coverage

1 source · 8 Oct 2026

◆ Related on Wire

◆ Topics

Medtechregulatory-approvalspinal-implantslatin-americamedtechmarket-entry